Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells

American Journal of Transplantation

Volumn 10, Issue 8, 2010, Pages 1760-1773

  Ge, W ^a   Jiang, J ^b   Liu, W ^a,b   Lian, D ^b   Saito, A ^a   Garcia, B ^a   Li, X C ^c   Wang, H ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allograft tolerance; memory T cells; regulatory T cells; sensitized recipients; transplantation

Indexed keywords

CD44V ANTIGEN; CD45RB ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LF15 0195; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45RB; MONOCLONAL ANTIBODY OX40 LIGAND; OX40 LIGAND; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; SKIN GRAFT; T CELL DEPLETION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; HEART TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TUMOR NECROSIS FACTORS;

EID: 77954946941     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03186.x     Document Type: Article

References (68)

1. Bingaman AW, Farber DL. Memory T cells in transplantation: Generation, function, and potential role in rejection. Am J Transplant 2004 4 : 846 852.
2. Valujskikh A, Lakkis FG. In remembrance of things past: Memory T cells and transplant rejection. Immunol Rev 2003 196 : 65 74.
3. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999 163 : 2267 2275.
4. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 2006 176 : 770 777.
5. Zhai Y, Meng L, Gao F, Ritchie SC, Kupiec-Weglinski JW. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 2002 169 : 434 438.
6. Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: Therapeutic implications for sensitized transplant recipients. J Immunol 2002 169 : 4667 4673.
7. Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002 2 : 501 509.
8. Cerny A, Ramseier H, Bazin H, Zinkernagel RM. Unimpaired first-set and second-set skin graft rejection in agammaglobulinemic mice. Transplantation 1988 45 : 1111 1113.
9. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. II. The nature of memory cells mediating second set heart graft rejection. J Exp Med 1978 148 : 890 902.
10. Hancock WW, Gao W, Shemmeri N et al. Immunopathogenesis of accelerated allograft rejection in sensitized recipients: Humoral and nonhumoral mechanisms. Transplantation 2002 73 : 1392 1397.
11. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002 13 : 252 259.
12. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol 2000 165 : 3043 3050.
13. Maxwell JR, Weinberg A, Prell RA, Vella AT. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol 2000 164 : 107 112.
14. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001 15 : 445 455.
15. Mallett S, Fossum S, Barclay AN. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor. Embo J 1990 9 : 1063 1068.
16. Miura S, Ohtani K, Numata N et al. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 1991 11 : 1313 1325.
17. Baum PR, Gayle RB, 3rd., Ramsdell F et al. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. Embo J 1994 13 : 3992 4001.
18. Godfrey WR, Fagnoni FF, Harara MA, Buck D, Engleman EG. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med 1994 180 : 757 762.
19. Paterson DJ, Jefferies WA, Green JR et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987 24 : 1281 1290.
20. Chen AI, McAdam AJ, Buhlmann JE et al. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999 11 : 689 698.
21. Kopf M, Ruedl C, Schmitz N et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999 11 : 699 708.
22. Murata K, Ishii N, Takano H et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 2000 191 : 365 374.
23. Salek-Ardakani S, Song J, Halteman BS et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003 198 : 315 324.
24. Zaini J, Andarini S, Tahara M et al. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J Clin Invest 2007 117 : 3330 3338.
25. Pippig SD, Pena-Rossi C, Long J et al. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J Immunol 1999 163 : 6520 6529.
26. Soroosh P, Ine S, Sugamura K, Ishii N. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity. J Immunol 2006 176 : 5975 5987.
27. Takasawa N, Ishii N, Higashimura N et al. Expression of gp34 (OX40 ligand) and OX40 on human T cell clones. Jpn J Cancer Res 2001 92 : 377 382.
28. Yuan X, Salama AD, Dong V et al. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol 2003 170 : 2949 2955.
29. Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 2006 176 1394 1401.
30. Demirci G, Amanullah F, Kewalaramani R et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol 2004 172 : 1691 1698.
31. Takeda I, Ine S, Killeen N et al. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 2004 172 : 3580 3589.
32. Vu MD, Xiao X, Gao W et al. OX40 costimulation turns off Foxp3+ Tregs. Blood 2007 110 : 2501 2510.
33. Chen M, Xiao X, Demirci G, Li XC. OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs. Transplantation 2008 85 : 1659 1662.
34. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: A novel regulatory role for OX40 and its comparison with GITR. Blood 2005 105 : 2845 2851.
35. Simpson D. Synergistic tolerance induction. Transplantation 2001 10 1381 1386.
36. Min WP, Zhou D, Huang X et al. LF15-0195 generates tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003 74 : 438 447.
37. Olfert ED, Cross BM McWilliam AA. Responsibility for the care and use of experimental animals. In : Olfert ED, Cross BM, McWilliam AA eds. Guide to the Care and Use of Experimental Animals (Vol 1).
38. Wang H, Arp J, Liu W et al. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. J Immunol 2007 179 : 4451 4463.
39. Wang H, Ge W, Arp J et al. Free bone graft attenuates acute rejection and in combination with cyclosporin A leads to indefinite cardiac allograft survival. J Immunol 2009 182 : 5970 5981.
40. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
41. Wang H, Hosiawa KA, Min W et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 2003 171 : 3823 3836.
42. Wang H, Arp J, Huang X et al. Distinct subsets of dendritic cells regulate the pattern of acute xenograft rejection and susceptibility to cyclosporine therapy. J Immunol 2006 176 : 3525 3535.
43. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: New diagnostic insights and standards. Am J Transplant 2004 4 : 1562 1566.
44. Ge W, Jiang J, Baroja ML et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009 9 : 1760 1772.
45. Min WP, Zhou D, Ichim TE et al. Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells. Transplantation 2003 75 : 1160 1165.
46. Min WP, Zhou D, Ichim TE et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003 170 : 1304 1312.
47. Wang H, Hosiawa KA, Garcia B et al. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model. Xenotransplantation 2003 10 : 325 336.
48. Wang H, Hosiawa KA, Garcia B et al. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model. Transplantation 2003 75 : 1475 1481.
49. Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000 192 : 303 310.
50. Ceredig R, Lowenthal JW, Nabholz M, MacDonald HR. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 1985 314 : 98 100.
51. Yamada A, Salama AD, Sayegh MH. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 2002 13 : 559 575.
52. Curry AJ, Chikwe J, Smith XG et al. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 2004 78 : 807 814.
53. Fujii H, Takada T, Nemoto K et al. Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. J Antibiot (Tokyo) 1990 43 : 213 219.
54. Josien R, Pannetier C, Douillard P et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995 60 : 1131 1139.
55. Cuturi MC, Josien R, Cantarovich D et al. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats. Eur J Immunol 1994 24 : 1627 1631.
56. Tepper MA, Nadler SG, Esselstyn JM, Sterbenz KG. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol 1995 155 : 2427 2436.
57. Wang B, Benoist C, Mathis D. The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation. J Exp Med 1996 183 : 2427 2436.
58. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001 2 : 58 63.
59. Salvalaggio PR, Camirand G, Ariyan CE et al. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo. J Immunol 2006 176 : 2292 2298.
60. Luke PP, Deng JP, O'Brien CA et al. Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells. Transplantation 2003 76 : 400 409.
61. Luke PP, Deng JP, Lian D et al. Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions. Am J Transplant 2006 6 : 2023 2034.
62. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007 120 : 238 244 quiz 245 236.
63. De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol 2002 168 : 661 670.
64. Yanagita S, Hori T, Matsubara Y, Ishikawa T, Uchiyama T. Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity. Br J Haematol 2004 124 : 454 462.
65. So T, Croft M. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J Immunol 2007 179 : 1427 1430.
66. Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2007 104 : 18169 18174.
67. Xiao X, Kroemer A, Gao W, Ishii N, Demirci G, Li XC. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo. J Immunol 2008 181 : 3193 3201.
68. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007 7 : 610 621.